King R, Khoriaty R
Blood Cells Mol Dis. 2025; 111:102910.
PMID: 39938185
PMC: 11884990.
DOI: 10.1016/j.bcmd.2025.102910.
Saito H
Nagoya J Med Sci. 2024; 86(3):361-369.
PMID: 39355366
PMC: 11439605.
DOI: 10.18999/nagjms.86.3.361.
Lilienthal P, Tetschke M, Schalk E, Fischer T, Sager S
Front Physiol. 2020; 11:328.
PMID: 32362837
PMC: 7180210.
DOI: 10.3389/fphys.2020.00328.
Saito H
Nagoya J Med Sci. 2018; 80(4):475-485.
PMID: 30587862
PMC: 6295426.
DOI: 10.18999/nagjms.80.4.475.
Oikonomidou P, Rivella S
Blood Rev. 2017; 32(2):130-143.
PMID: 29054350
PMC: 5882559.
DOI: 10.1016/j.blre.2017.10.001.
Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory.
Donker A, Schaap C, Novotny V, Smeets R, Peters T, van den Heuvel B
Am J Hematol. 2016; 91(12):E482-E490.
PMID: 27643674
PMC: 6586001.
DOI: 10.1002/ajh.24561.
New strategies to target iron metabolism for the treatment of beta thalassemia.
Oikonomidou P, Casu C, Rivella S
Ann N Y Acad Sci. 2016; 1368(1):162-8.
PMID: 26919168
PMC: 5271577.
DOI: 10.1111/nyas.13018.
METABOLISM OF IRON STORES.
Saito H
Nagoya J Med Sci. 2015; 76(3-4):235-254.
PMID: 25741033
PMC: 4345694.
Exploring Staphylococcus aureus pathways to disease for vaccine development.
DeDent A, Kim H, Missiakas D, Schneewind O
Semin Immunopathol. 2011; 34(2):317-33.
PMID: 22130613
PMC: 3539746.
DOI: 10.1007/s00281-011-0299-z.
Effect of Desferrioxamine and D.T.P.A. in Iron Overload.
Bannerman R, CALLENDER S, Williams D
Br Med J. 2010; 2(5319):1573-7.
PMID: 20789564
PMC: 1926807.
DOI: 10.1136/bmj.2.5319.1573.
Discussion on Clinical and Experimental Studies with Radioactive Iron.
Proc R Soc Med. 2009; 49(10):863-70.
PMID: 19993894
PMC: 1889205.
Ineffective erythropoiesis and thalassemias.
Rivella S
Curr Opin Hematol. 2009; 16(3):187-94.
PMID: 19318943
PMC: 3703923.
DOI: 10.1097/MOH.0b013e32832990a4.
Targeting erythroblast-specific apoptosis in experimental anemia.
Diwan A, Koesters A, Capella D, Geiger H, Kalfa T, Dorn 2nd G
Apoptosis. 2008; 13(8):1022-30.
PMID: 18584327
PMC: 2556039.
DOI: 10.1007/s10495-008-0236-3.
Relative polycythemia; the polycythemia of stress.
LAWRENCE J, BERLIN N
Yale J Biol Med. 1952; 24(6):498-505.
PMID: 14951396
PMC: 2599279.
The rate of removal of radioactive iron from the plasma; an index of erythropoiesis.
WASSERMAN L, RASHKOFF I, Leavitt D, Mayer J, PORT S
J Clin Invest. 1952; 31(1):32-9.
PMID: 14907878
PMC: 436379.
DOI: 10.1172/JCI102574.
Ferrokinetics in normal persons and in patients having various erythropoietic disorders.
HUFF R, ELMLINGER P, Garcia J, ODA J, COCKRELL M, LAWRENCE J
J Clin Invest. 1951; 30(12:2):1512-26.
PMID: 14897912
PMC: 441324.
DOI: 10.1172/JCI102562.
Studies in glycine-2-C14 metabolism in man. I. The pulmonary excretion of C14O2.
BERLIN N, TOLBERT B, LAWRENCE J
J Clin Invest. 1951; 30(1):73-6.
PMID: 14803559
PMC: 436229.
DOI: 10.1172/JCI102418.
Iron and protein kinetics studied by means of doubly labeled human crystalline transferrin.
KATZ J
J Clin Invest. 1961; 40:2143-52.
PMID: 14454385
PMC: 290922.
DOI: 10.1172/JCI104440.
The role of the kidney in erythropoiesis.
NAETS J
J Clin Invest. 1960; 39:102-10.
PMID: 14425757
PMC: 290668.
DOI: 10.1172/JCI104008.
The determination of iron in plasma or serum.
BOTHWELL T, MALLETT B
Biochem J. 1955; 59(4):599-602.
PMID: 14363152
PMC: 1215623.
DOI: 10.1042/bj0590599.